Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Outlook Therapeutics (OTLK) Long-Term Debt Issuances (2016 - 2017)

Outlook Therapeutics (OTLK) has disclosed Long-Term Debt Issuances for 3 consecutive years, with $5.0 million as the latest value for Q2 2017.

  • Quarterly Long-Term Debt Issuances rose 3067584.66% to $5.0 million in Q2 2017 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Sep 2025, changed N/A year-over-year, with the annual reading at $33.1 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q2 2017 was $5.0 million at Outlook Therapeutics, up from $1.6 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $8.4 million in Q4 2016, with the low at -$163.0 in Q2 2016.
  • Average Long-Term Debt Issuances over 3 years is $2.1 million, with a median of $1.0 million recorded in 2015.
  • The sharpest move saw Long-Term Debt Issuances crashed 100.01% in 2016, then soared 3067584.66% in 2017.
  • Over 3 years, Long-Term Debt Issuances stood at $187388.0 in 2015, then skyrocketed by 4356.0% to $8.4 million in 2016, then tumbled by 40.12% to $5.0 million in 2017.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at $5.0 million, $1.6 million, and $8.4 million for Q2 2017, Q1 2017, and Q4 2016 respectively.